ω3製剤Lovaza 症候性心房細動再発予防効果認めず

Lovaza (Omega-3-Acid Ethyl Esters) の治験


心房細動に対する治療のω3 PUFAの有効性トライアルで、再発症候性心房細動予防検討

有効性示せなかった

Efficacy and Safety of Prescription Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation

A Randomized Controlled Trial

Peter R. Kowey, MD; James A. Reiffel, MD; Kenneth A. Ellenbogen, MD; Gerald V. Naccarelli, MD; Craig M. Pratt, MD

JAMA. Published online November 15, 2010. doi:10.1001/jama.2010.1735


First Re
currence of Symptomatic Atrial Fibrillation for the Paroxysmal Stratum

by internalmedicine | 2010-11-16 09:02 | 動脈硬化/循環器  

<< 院外症例と異なり、入院心停止患... 冠動脈検査のための累積放射線実... >>